BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BHG Acquires Valhalla Place, Expands into MN

The four locations, jointly employing 185 clinicians, counselors, and staff treat more than 3,000 patients with opioid use disorder. BHG will als...

November 11, 2021 | News

Labcorp and National Kidney Foundation Promote Patient Registry to Enhance Clinical Trial Accessibility, Diversity

-Labcorp (NYSE: LH), a leading global life sciences company, and the National Kidney Foundation (NKF), the largest patient organization dedicated to t...

November 08, 2021 | News

New discovery: Banana beats insomnia and anti-anxiety, approved by the US FDA

The TCI in Taiwan announced that its "Banana Peel, Banana Stamen" has received the FDA's new dietary supplement ingredient NDI safety response, a...

November 02, 2021 | News

China to Accelerate Innovations in Chronic Disease Management

The agreement will allow 111 and Chugai Pharma China to work together towards building a "Healthy China" by establishing a "SMART Healthcare City" concept ...

October 26, 2021 | News

Columbia opens its third and largest hospital in Jiaxing, China

Jiaxing Kaiyi Hospital is licensed for 500 beds with a construction area of 112,000 square meters. It is built in accordance to Joint Commission Inte...

October 25, 2021 | News

QIAGEN launches novel QIAreach QuantiFERON-TB tuberculosis test for high-burden regions

QIAGEN leverages QuantiFERON®-TB technology to advance global efforts against TB TB IGRA testing now accessible in high burden, low resource and dec...

October 21, 2021 | News

MSN Labs Launches Empagliflozin tablets at an affordable price for Diabetes Management in India

‘EMPAONE’ is intended to provide diabetes patients in need across India with an affordable and accessible therapeutic option. India being the d...

October 19, 2021 | News

MYND to Participate in a Monash University (Australia) Proposal for $3 Million Clinical Trial

MYND Diagnostics Inc., a wholly-owned subsidiary of MYND Life Sciences (CSE: MYND) (OTC: MYNDF) is pleased to announce that the Company's pr...

October 18, 2021 | News

Fujitsu and University of Tokyo Hospital Embark on Joint Research into AI to Aid the Fight Against Heart Disease

News Facts:- Fujitsu and the University of Tokyo Hospital validate the effectiveness of proprietary AI technology that uses electrocardiographic data...

October 11, 2021 | News

FDA Approves Innovative Treatment for Pediatric Patients with Congenital Athymia

"Today's action marks the first FDA approval of a therapy to treat this very rare and devastating disease in children," said Peter Marks, M.D., Ph.D.,...

October 11, 2021 | News

Zuellig Pharma Receives EcoVadis Platinum Medal in 2021 For Sustainability

The award is the highest accolade to be awarded to a company for its sustainability efforts and positions Zuellig Pharma in the top 1% of all assessed comp...

October 05, 2021 | News

Japan Approves Pfizer’s CIBINQO® to treat Atopic Dermatitis

Pfizer Inc. (NYSE: PFE) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved CIBINQO® (abrocitinib), ...

October 04, 2021 | News

Sanofi Consumer Healthcare expands mental health pillar

Sanofi's Consumer Healthcare business unit – the country's largest multinational pharmaceutical company – continues to expand its good wor...

October 01, 2021 | News

South Korea Advances Treatment of Polymyositis

Immunoforge (Co-CEOs Sung-min Ahn, Kiho Chang), a company specializing in developing new drugs for rare musculoskeletal diseases, has reported that th...

September 28, 2021 | News

Stay Connected